Aaron Kimball Biography and Net Worth

CTO of Zymergen

Prior to joining Zymergen, Aaron co-founded WibiData, and he was the first employee at Cloudera. Aaron holds a BS from Cornell University and an MS from the University of Washington, both in Computer Science. He holds several patents on predictive modeling for microbial engineering.

What is Aaron Kimball's net worth?: The estimated net worth of Aaron Kimball is at least $1.73 million as of April 1st, 2022. Mr. Kimball owns 712,644 shares of Zymergen stock worth more than $1,731,725 as of November 24th. This net worth evaluation does not reflect any other assets that Mr. Kimball may own. Learn More about Aaron Kimball's net worth.
How do I contact Aaron Kimball?: The corporate mailing address for Mr. Kimball and other Zymergen executives is , , . Zymergen can also be reached via phone at 415-801-8073 and via email at [email protected]. Learn More on Aaron Kimball's contact information.
Has Aaron Kimball been buying or selling shares of Zymergen?: Aaron Kimball has not been actively trading shares of Zymergen during the past quarter. Most recently, Aaron Kimball sold 32,639 shares of the business's stock in a transaction on Friday, April 1st. The shares were sold at an average price of $2.87, for a transaction totalling $93,673.93. Following the completion of the sale, the chief technology officer now directly owns 712,644 shares of the company's stock, valued at $2,045,288.28. Learn More on Aaron Kimball's trading history.
Who are Zymergen's active insiders?: Zymergen's insider roster includes Jay Flatley (CEO), Aaron Kimball (CTO), and Zachariah Serber (Insider). Learn More on Zymergen's active insiders.

Aaron Kimball Insider Trading History at Zymergen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2022	Sell	32,639	$2.87	$93,673.93	712,644
2/1/2022	Sell	25,000	$5.06	$126,500.00
1/18/2022	Sell	50,000	$5.18	$259,000.00

Aaron Kimball Buying and Selling Activity at Zymergen

Zymergen Company Overview

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Today's Range

Now: $2.43

$2.43

50 Day Range

MA: $2.52

$2.35

$3.14

2 Week Range

Now: $2.43

$1.10

$12.42

Volume

85 shs

Average Volume

1,229,575 shs

Market Capitalization

$253.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.